SIL1
Nucleotide exchange factor SIL1
Also known as: BAP, MSS, SIL1_HUMAN, ULG5
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H173
- Gene
- SIL1
- Ensembl
- ENSG00000120725
- Chromosome
- 5
- Canonical length
- 461 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
This gene encodes a resident endoplasmic reticulum (ER), N-linked glycoprotein with an N-terminal ER targeting sequence, 2 putative N-glycosylation sites, and a C-terminal ER retention signal. This protein functions as a nucleotide exchange factor for another unfolded protein response protein. Mutations in this gene have been associated with Marinesco-Sjogren syndrome. Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
461 residues, UniProt reviewed canonical sequence.
>Q9H173|SIL1
1 MAPQSLPSSR MAPLGMLLGL LMAACFTFCL SHQNLKEFAL TNPEKSSTKE TERKETKAEE
61 ELDAEVLEVF HPTHEWQALQ PGQAVPAGSH VRLNLQTGER EAKLQYEDKF RNNLKGKRLD
121 INTNTYTSQD LKSALAKFKE GAEMESSKED KARQAEVKRL FRPIEELKKD FDELNVVIET
181 DMQIMVRLIN KFNSSSSSLE EKIAALFDLE YYVHQMDNAQ DLLSFGGLQV VINGLNSTEP
241 LVKEYAAFVL GAAFSSNPKV QVEAIEGGAL QKLLVILATE QPLTAKKKVL FALCSLLRHF
301 PYAQRQFLKL GGLQVLRTLV QEKGTEVLAV RVVTLLYDLV TEKMFAEEEA ELTQEMSPEK
361 LQQYRQVHLL PGLWEQGWCE ITAHLLALPE HDAREKVLQT LGVLLTTCRD RYRQDPQLGR
421 TLASLQAEYQ VLASLELQDG EDEGYFQELL GSVNSLLKEL RLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SIL1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 64 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 64 nTPM
- choroid plexus: 53 nTPM
- liver: 52 nTPM
- testis: 48 nTPM
- adrenal gland: 46 nTPM
- skeletal muscle: 41 nTPM
Single-cell type
- late spermatids: 346 nCPM
- plasma cells: 318 nCPM
- myonuclei: 304 nCPM
- somatotrophs: 290 nCPM
- hematopoietic stem cells: 289 nCPM
- podocytes: 268 nCPM
Immune cell
- intermediate monocyte: 52 nTPM
- myeloid DC: 51 nTPM
- classical monocyte: 48 nTPM
- non-classical monocyte: 43 nTPM
- plasmacytoid DC: 37 nTPM
- total PBMC: 27 nTPM
Brain region
- choroid plexus: 43 nTPM
- thalamus: 29 nTPM
- medulla oblongata: 27 nTPM
- pons: 27 nTPM
- basal ganglia: 26 nTPM
- midbrain: 26 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SIL1.
Disease | AllUniProt
Conditions SIL1 is implicated in, by any mechanism.
- Marinesco-Sjoegren syndrome (MSS) MIM:248800
Disease | GeneticClinVar
35 pathogenic / likely-pathogenic of 422 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Marinesco-Sjögren syndrome
- See cases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.64
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.47
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SIL1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SIL1 as an antibody target. Whether an autoantibody or antibody against SIL1 could matter depends on whether native SIL1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SIL1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SIL1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...